Company intelligence / Profile preview

NeuroHealing Pharmaceuticals, Inc.

Newton, Massachusetts, United Statesorpha.net ↗

Ownership: Private
Employees: ~3
Development stage: Phase 2

Overview

NeuroHealing Pharmaceuticals developed therapies for neuro-rehabilitation following CNS injuries using repurposed drugs with established safety profiles. Lead candidates included agents for coma emergence, sialorrhea management, and post-stroke rehabilitation. The company had several clinical-stage assets but does not appear to have advanced any program to late-stage or commercial approval.

Therapeutic areas: Men's HealthNeurology
Modalities: Small molecules (repurposed neurologically active compounds)
Industry: Biotech

Drug pipeline

3 assets

NH004

2 more assets in the full pipeline.

Request access →

Partnerships

Life Science Angels (investor partnership)No major pharma partnerships disclosed

Beyond the preview

Go deeper on NeuroHealing Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroHealing Pharmaceuticals, Inc..

Explore the full profile